Medical Use of Cannabis Tied to Higher Prevalence of Cannabis Use Disorder
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 23, 2025 -- Adults aged 18 to 49 years reporting medical-only or medical-nonmedical cannabis use may have a higher prevalence of cannabis use disorder (CUD) than those reporting nonmedical only, according to a research letter published online Jan. 22 in JAMA Psychiatry.
Beth Han, M.D., Ph.D., M.P.H., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined differences in cannabis use frequency and CUD prevalence for medical-only and medical-nonmedical versus nonmedical-only use among U.S. adults aged 18 to 49 years. The analysis included data from 72,668 participants in the 2021 to 2022 National Surveys on Drug Use and Health.
The researchers found that 29.5 percent of respondents reported past-year cannabis use: 83.7 percent for nonmedical-only use, 9.2 percent medical-only use, and 5.7 percent for medical-nonmedical use. More than one-third (34.8 percent) had CUD. A higher adjusted prevalence of severe, moderate, and mild CUD was seen among men and women aged 18 to 34 years and men aged 35 to 49 years reporting medical-only or medical-nonmedical use versus those reporting nonmedical-only use. Adults reporting medical-only or medical-nonmedical use had more days of cannabis use than those reporting nonmedical-only use.
"Clinicians should consider addiction risk before recommending medical cannabis and, if they do, should monitor for CUD emergence," the authors write.
One author disclosed having long-term stocks with relevant companies.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma
WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large...
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes
WEDNESDAY, June 25, 2025 -- The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early...
Paternal Mental Distress Linked to Poorer Offspring Development
WEDNESDAY, June 25, 2025 -- Paternal mental distress is associated with poorer child development, according to a study published online June 16 in JAMA Pediatrics. Genevieve Le...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.